Ferla, R. Et Al. 2015. Prevalence of Anti-AAV8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial. 18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) , (Louisiana, United States Of America).

Ferla, R., Claudiani, P., Savarese, M., Kozarsky, K., Parini, R., Scarpa, M., ... Donati, M. A.(2015). Prevalence of Anti-AAV8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial . 18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Louisiana, United States Of America

Ferla, Rita Et Al. "Prevalence of Anti-AAV8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial," 18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Louisiana, United States Of America, 2015

Ferla, Rita Et Al. "Prevalence of Anti-AAV8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial." 18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) , Louisiana, United States Of America, 2015

Ferla, R. Et Al. (2015) . "Prevalence of Anti-AAV8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial." 18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) , Louisiana, United States Of America.

@conferencepaper{conferencepaper, author={Rita Ferla Et Al. }, title={Prevalence of Anti-AAV8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial}, congress name={18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)}, city={Louisiana}, country={United States Of America}, year={2015}}